Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Regeneron
Regeneron
Chronic hives: Four major clinical trials to watch in 2023
Clinical Trials Arena
Wed, 05/3/23 - 11:53 am
chronic hives
chronic urticaria
clinical trials
Sanofi
Regeneron
dupilumab
Amgen
tezepelumab
Allakos
lirentelimab
Celldex Therapeutics
barzolvolimab
Alnylam’s early Alzheimer’s results encourage, but company discloses new hurdle
BioPharma Dive
Fri, 04/28/23 - 10:08 am
Alnylam
Regeneron
clinical trials
Alzheimer's disease
ALN-APP
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access
Fierce Pharma
Wed, 04/26/23 - 05:50 pm
AbbVie
Amgen
Bristol Myers Squibb
Eli Lilly
Gilead Sceinces
JNJ
Merck
Pfizer
Regeneron
patents
activists
Roche’s new eye drug pressures Eylea with strong launch
BioPharma Dive
Wed, 04/26/23 - 05:44 pm
Roche
Vabysmo
Eylea
earnings
Regeneron
After massive equity awards, Regeneron's top 2 execs collected smaller pay packages in 2022
Fierce Pharma
Mon, 04/24/23 - 11:18 pm
Regeneron
exective pay
George Yancopoulos
Len Schleifer
Big pharma holds steady on research spending
EP Vantage
Fri, 04/21/23 - 10:03 am
R&D
AbbVie
Amgen
AstraZeneca
Bayer
Biogen
Bristol Myers Squibb
Eli Lilly
Gilead Sciences
GSK
JNJ
Merck
Merck KGaA
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
UCB
Vertex Pharmaceuticals
REGN5459 Delivers Dose-Dependent Responses in Relapsed/Refractory Myeloma
Onc Live
Tue, 04/18/23 - 09:49 am
Regeneron
AACR
REGN5459
relapsed or refractory multiple myeloma
The end of an era: Regeneron chairman Roy Vagelos to retire after 29-year run
Fierce Pharma
Mon, 04/17/23 - 12:01 pm
Regeneron
Roy Vagelos
Len Schleifer
George Yancopoulos
Regeneron expects $56M IPR&D charge tied to cell therapy pact
Fierce Biotech
Mon, 04/10/23 - 04:53 pm
Regeneron
earnings
R&D
Sonoma Biotherapeutics
Biopharma stocks go back to bleak
EP Vantage
Thu, 04/6/23 - 09:51 am
Albireo Pharma
Amryt Pharma
Apellis Pharmaceuticals
AstraZeneca
BridgeBio
Novo Nordisk
Pfizer
Protagonist Therapeutics
Provention Bio
Reata Pharmaceuticals
Regeneron
Sanofi
Seagen
5 FDA decisions to watch in the second quarter
BioPharma Dive
Mon, 04/3/23 - 11:06 pm
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Biogen
tofersen
ALS
Seres Therapeutics
C. difficile
Pfizer
GSK
vaccines
RSV
Regeneron
Eylea
Regeneron bets on ‘Treg’ cell therapy with Sonoma deal
BioPharma Dive
Tue, 03/28/23 - 10:26 am
Regeneron
Sonoma Biotherapeutics
autoimmune disease
cell therapy
Treg cell therapy
Sanofi, Regeneron's Dupixent could hit $20B in peak sales with COPD expansion: analyst
Fierce Pharma
Sun, 03/26/23 - 11:30 pm
Sanofi
Regeneron
Dupixent
COPD
Sanofi and Regeneron's Dupixent scores trial win in tough-to-treat COPD
Fierce Pharma
Thu, 03/23/23 - 11:44 am
Sanofi
Regeneron
Dupixent
COPD
clinical trials
FDA expands use of Regeneron's HoFH drug Evkeeza to kids 5 and up
Fierce Pharma
Wed, 03/22/23 - 11:14 am
Regeneron
Evkeeza
pediatric
Homozygous Familial Hypercholesterolemia
FDA
AAD: Will Sanofi and Regeneron’s Dupixent be a game-changer or just another antibody on the COPD scrapheap?
Fierce Pharma
Mon, 03/20/23 - 10:06 am
Sanofi
Regeneron
Dupixent
COPD
FDA Approves Regeneron-Sanofi's Sarilumab As First Biologic For Stiffness, Pain In Muscles
Yahoo/Benzinga
Wed, 03/1/23 - 07:07 pm
Regeneron
Sanofi
FDA
Kevzara
Sarilumab
polymyalgia rheumatica
Go or no go? Vaccines and neurology up for discussion
EP Vantage
Tue, 02/28/23 - 11:05 am
FDA
Acadia Pharmaceuticals
Apellis Pharmaceuticals
AstraZeneca
Biogen
Biomarin
Cidara Therapeutics
Emergent BioSolutions
GSK
Incyte
Ionis Pharmaceuticals
Melinta Therapeutics
Mundipharma
Novartis
Pfizer
Pharming
Regeneron
Roche
vaccines
RSV
ALS
COVID-19
Sanofi and Regeneron face a high-risk test for Dupixent
EP Vantage
Fri, 02/17/23 - 10:20 am
Sanofi
Regeneron
Dupixent
COPD
clinical trials
US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case
Endpoints
Mon, 02/13/23 - 10:12 pm
Pfizer
Viatris
Sanofi
Regeneron
patents
Supreme Court
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »